2/10
04:41 pm
lbrx
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
2/5
08:00 am
lbrx
LB Pharmaceuticals Announces $100.0 Million Private Placement
Medium
Report
LB Pharmaceuticals Announces $100.0 Million Private Placement
1/27
08:33 am
lbrx
LB Pharmaceuticals initiates Phase 2 trial of LB-102 [Yahoo! Finance]
Low
Report
LB Pharmaceuticals initiates Phase 2 trial of LB-102 [Yahoo! Finance]
1/26
08:00 am
lbrx
LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development Program
Medium
Report
LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development Program
1/21
08:00 am
lbrx
LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel
Low
Report
LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel
1/12
04:05 pm
lbrx
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
1/10
05:43 am
lbrx
LB Pharmaceuticals (NASDAQ:LBRX) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Medium
Report
LB Pharmaceuticals (NASDAQ:LBRX) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
1/9
05:03 am
lbrx
LB Pharmaceuticals (NASDAQ:LBRX) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.
Low
Report
LB Pharmaceuticals (NASDAQ:LBRX) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.
2/17
04:37 pm
lbrx
Form SCHEDULE 13G/A LB PHARMACEUTICALS INC Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13G/A LB PHARMACEUTICALS INC Filed by: RA CAPITAL MANAGEMENT, L.P.
2/10
04:31 pm
lbrx
Form SCHEDULE 13D/A LB PHARMACEUTICALS INC Filed by: Deep Track Capital, LP
Low
Report
Form SCHEDULE 13D/A LB PHARMACEUTICALS INC Filed by: Deep Track Capital, LP
2/10
04:30 pm
lbrx
Form 4 LB PHARMACEUTICALS INC For: Feb 06 Filed by: Deep Track Special Opportunities Fund, LP
Low
Report
Form 4 LB PHARMACEUTICALS INC For: Feb 06 Filed by: Deep Track Special Opportunities Fund, LP
2/5
08:15 am
lbrx
Form 8-K LB PHARMACEUTICALS INC For: Feb 04
Medium
Report
Form 8-K LB PHARMACEUTICALS INC For: Feb 04
1/21
12:32 pm
lbrx
Form SCHEDULE 13G LB PHARMACEUTICALS INC Filed by: BlackRock, Inc.
Low
Report
Form SCHEDULE 13G LB PHARMACEUTICALS INC Filed by: BlackRock, Inc.
1/21
12:27 pm
lbrx
Form SCHEDULE 13G/A LB PHARMACEUTICALS INC Filed by: BlackRock Portfolio Management LLC
Low
Report
Form SCHEDULE 13G/A LB PHARMACEUTICALS INC Filed by: BlackRock Portfolio Management LLC
1/21
08:14 am
lbrx
Form SCHEDULE 13G LB PHARMACEUTICALS INC Filed by: JPMORGAN CHASE & CO
Low
Report
Form SCHEDULE 13G LB PHARMACEUTICALS INC Filed by: JPMORGAN CHASE & CO
12/31
05:00 pm
lbrx
Form SCHEDULE 13G LB PHARMACEUTICALS INC Filed by: Trails Edge Capital Partners, LP
Medium
Report
Form SCHEDULE 13G LB PHARMACEUTICALS INC Filed by: Trails Edge Capital Partners, LP
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register